{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:59:44Z","timestamp":1787727584090,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mayocpiqo.2025.100627","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T23:48:26Z","timestamp":1747957706000},"page":"100627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Randomized Trial of At-Home COVID-19 Tests, Telemedicine, and Rapid Prescription Delivery for Immunocompromised Individuals"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-3540","authenticated-orcid":false,"given":"Julia Moore","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vik","family":"Kheterpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Quer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Topol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100627_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004086","article-title":"Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study","volume":"20","author":"Turtle","year":"2023","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2025.100627_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12325-023-02754-0","article-title":"Assessing the burden and cost of COVID-19 across variants in commercially insured immunocompromised populations in the United States: updated results and trends from the ongoing EPOCH-US study","volume":"41","author":"Ketkar","year":"2024","journal-title":"Adv Ther"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2025.100627_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006434","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Romero Starke","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"23","key":"10.1016\/j.mayocpiqo.2025.100627_bib4","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2025.100627_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US Adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.mayocpiqo.2025.100627_bib8","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2025.100627_bib9","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S2665-9913(23)00160-1","article-title":"Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY","volume":"5","author":"Pearce","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100627_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12985-022-01858-3","article-title":"Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis","volume":"19","author":"Mehrabi Nejad","year":"2022","journal-title":"Virol J"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2025.100627_bib11","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/s41591-023-02414-4","article-title":"SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease","volume":"29","author":"Barnes","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2025.100627_bib12","doi-asserted-by":"crossref","first-page":"e1397","DOI":"10.1093\/cid\/ciab397","article-title":"Improving the outcomes of immunocompromised patients with coronavirus disease 2019","volume":"73","author":"Haidar","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2025.100627_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 variants in patients with immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2025.100627_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2025.100627_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe Covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2025.100627_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4920","article-title":"Prevalence of immunosuppressive drug use among commercially insured US adults, 2018-2019","volume":"4","author":"Wallace","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mayocpiqo.2025.100627_bib19","article-title":"Center for Devices, Radiological Health. Do not use Cue Health\u2019s COVID-19 tests due to risk of false results: FDA safety communication","year":"2024","journal-title":"US Food and Drug Administration"},{"issue":"27","key":"10.1016\/j.mayocpiqo.2025.100627_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15585\/mmwr.mm7127a3","article-title":"Factors associated with severe outcomes among immunocompromised adults hospitalized for COVID-19\u2014COVID-NET, 10 states, March 2020\u2013February 2022","volume":"71","author":"Singson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.mayocpiqo.2025.100627_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.15585\/mmwr.mm7316a2","article-title":"SARS-CoV-2 viral shedding and rapid antigen test performance\u2014respiratory virus transmission network, November 2022\u2013May 2023","volume":"73","author":"Smith-Jeffcoat","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mayocpiqo.2025.100627_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1148637","article-title":"To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study","volume":"11","author":"Chi","year":"2023","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2025.100627_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamainternmed.2022.1827","article-title":"Comparison of home antigen testing with RT-PCR and viral culture during the course of SARS-CoV-2 infection","volume":"182","author":"Chu","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100627_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41591-020-1123-x","article-title":"Wearable sensor data and self-reported symptoms for COVID-19 detection","volume":"27","author":"Quer","year":"2021","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2025.100627_bib27","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S2589-7500(24)00096-7","article-title":"Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralised, randomised controlled trial","volume":"6","author":"Quer","year":"2024","journal-title":"Lancet Digit Health"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454825000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454825000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T07:12:24Z","timestamp":1749453144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454825000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2542454825000384"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2025.100627","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Trial of At-Home COVID-19 Tests, Telemedicine, and Rapid Prescription Delivery for Immunocompromised Individuals","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2025.100627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}],"article-number":"100627"}}